DYNEX, in cooperation with the renowned German manufacturer QIAGEN, is launching a new test for the new coronavirus SARS-CoV-2 causing COVID-19. The test is part of the QIAstat-Dx RUO Respiratory Panel, which detects and differentiates 21 other bacterial and viral pathogens.
The QIAstat-Dx platform is already located in several diagnostic laboratories in the Czech Republic. It is intended for the so-called syndromic testing (multiplex real-time PCR method), where all common pathogens associated with a particular syndrome are tested. Thus, in the case of a panel containing a new coronavirus, other respiratory diseases are also detected. QIAstat-Dx can also be used for urgent diagnostics - the result is known about an hour after sample insertion. The operation of the analyzer is straightforward, pipette the sample into the cassette or insert directly the sample swab (nasopharyngeal swab).
Doctors want accurate and timely answers. Patients want the right treatment. With the new QIAstat-Dx analyzer from QIAGEN, we can provide them all now, including the new coronavirus. More information about the product can be found here.